Polyethylene Glycol
Polyethylene Glycol is an FDA drug label for the active ingredient POLYETHYLENE GLYCOL manufactured by BluePoint Laboratories administered by ORAL. This page reproduces the FDA-approved indications and usage, dosage, contraindications, warnings, and adverse reactions exactly as published in the drug label. Data source: openFDA (U.S. FDA), label effective 20210920.
- Generic name
- POLYETHYLENE GLYCOL
- Manufacturer
- BluePoint Laboratories
- Product type
- HUMAN OTC DRUG
- Route
- ORAL
- Dosage form
- N/A
- NDC
- 68001-505
- Application
- ANDA091077
- Label effective
- 20210920
Active ingredients
Indications & Usage
USE Relieves occasional constipation (irregularity) Generally produces a bowel movement in 1 to 3 days
Dosage & Administration
DIRECTIONS do not take more than directed unless advised by your doctor the bottle top is a measuring cap marked to contain 17 grams of powder when filled to the indicated line. adults and children 17 years of age and older: use once a day fill to top of line in cap which is marked to indicate the correct dose (17 g) stir and dissolve in any 4 to 8 ounces of beverage (cold, hot or room temperature) then drink do not combine with starch-based thickeners used for difficulty swallowing ensure that the powder is fully dissolved before drinking do not drink if there are any clumps do not use more than 7 days children 16 years of age or under: ask a doctor
Contraindications
Not available.
Warnings
WARNINGS Allergy alert: Do not use if you are allergic to polyethylene glycol. Do not use if you have kidney disease, except under the advice and supervision of a doctor
Adverse Reactions
Not available.